Left ventricular (LV) hypertrophy, defined as an abnormal increase in LV mass (LVM), is an important prognostic indicator and therapeutic target. LVM is often divided by body surface area to derive indexed mass; however, this does not correctly identify pathological LV hypertrophy in all people, especially when body composition is altered, or in different ethnic groups. We evaluated published ranges of echocardiographic LVM in healthy adult populations from different countries, excluding control groups, and compared them with the American Society of Echocardiography reference ranges. A total of 33 studies met the inclusion criteria. In men and women, there was wide variation in the ranges of LVM with a tendency for the upper limit to increase geographically westward; this variation remained for indexed mass. Several ranges fell outside the upper reference limits: in men, 13 of the mass ranges and 16 of indexed mass; and in women, 8 mass and 16 indexed mass. This review has shown that current guidelines may need revision as some published series suggest that greater LV mass should be considered normal. This may be explained by ethnic differences and supports the need for widely applicable and ethnically diverse reference ranges to be established.
Introduction
Left ventricular hypertrophy (LVH) is an important prognostic indicator of cardiovascular (CV) events.
1,2 A progressive increase in left ventricular mass (LVM) correlates with exposure to high blood pressure, 1 and regression of LVM with pharmacotherapy can reduce the risk of CV events. 3 However, thresholds of LVM that are used to define LVH must be accurate if therapy is to be used in an appropriate and efficacious way.
In 2005, the American Society of Echocardiography (ASE), in conjunction with the European Association of Echocardiography, published recommendations for gender-specific reference ranges of LVM. 4 The reference ranges were derived from 510 normotensive, non-diabetic adults who were of normal weight and did not have recognised CV disease, and included people of Caucasian, African American and American Indian descent. The guidelines present ranges for measurements from m-mode and two-dimensional images, with the reference range of normal LVM defined as two standard deviations from the mean of the normal group.
In an attempt to adjust for variation in body composition, LVM is commonly indexed to body surface area (BSA). However, in health LVM is largely determined by lean body mass (LBM), 5, 6 and LVM indexed by BSA does not correctly identify pathological LVH in all people, especially when body composition is altered. 7 In addition, body composition varies across ethnic groups, 8, 9 and indexation to BSA may not account for the resultant variation in LVM. We hypothesised that there may be geographical differences in the range of LVM owing to different ethnic distribution and thus different body size and composition.
We evaluated the range of indexed and unindexed LVM found in normal healthy cohorts and compared them with the reference ranges for normal mass recommended by the ASE. Of particular interest is the geographical spread of cohorts, representing the distribution of ethnicities and generalised differences in body composition.
Methods
Identification of studies Studies were identified by searching Medline, Embase and Scopus databases using the keywords: echocardiography; reference: values, ranges, limits; normal: ranges, values; ventricular: mass, structure, volume, function and dimensions. Where applicable, keywords were searched as the root and a truncation symbol (for example, ventric*) and 'echocardiography' was exploded. All searches were limited to humans and to studies published between 1 January 1986 and 31 December 2009. There were no restrictions on the language of publication. In addition, reference lists of the studies eligible for inclusion in the final review were hand searched. Two separate searches were carried out by MEB and KKP and reviewed collectively to reach consensus, with final adjudication by GAW.
Criteria for study inclusion To be included in this review, studies were required to have recruited healthy volunteers, without CVD or CV symptoms, from the general population; and provide values of LVM and/or mass indexed to BSA.
A study was excluded if: it did not include adults; it was a special population (athletes, pregnant women and obese); the subjects were not screened for CVD or hypertension; it contained p20 normal subjects; or if the cohort was a control group. Studies were also excluded if summary statistics were not available and could not be obtained through direct communication with the authors.
Cohorts may have been represented by more than one study. To avoid undue influence being exerted by a single cohort, the study that was most compatible to those used to develop the reference ranges on the basis of exclusion criteria and measurement method was used in preference. If these factors were similar, the study that contained the greater number of subjects was selected.
Exclusion of control groups
Control groups of patients that have been referred for echocardiography or cardiac catheterisation, but have later been judged to be free of the disease of interest were excluded from this study on the basis that the referral may have been due to cardiac symptoms even if no disease was detected. Additionally, subjects referred for investigations such as cardiac catheterisation are not representative of the general population. Although referral to specialist cardiac services may be for routine asymptomatic reasons (such as assessment for medical insurance), the nature of this analysis means that we are unable to identify those potentially healthy subjects.
Analysis
Study level and gender-specific data for LVM and LVM indexed to BSA (LVMI) are presented as mean±two s.d. allowing direct comparison with the reference ranges recommended by the ASE. 4 If the mean and s.d. of the measurements could not be derived from the paper, or if the values were not stratified by gender, authors were contacted to obtain data in this form.
Mass values from images measured according to the current ASE recommendations (leading edge to leading edge of m-mode images), but not calculated using the ASE cube formula, 10 were converted to ASE values where possible. Values obtained using the Penn measuring convention and appropriate cube equation 11 were not adjusted as each method has been validated with necropsy. Where summary data were presented in a greater number of subgroups than needed for this analysis, a weighted mean and pooled s.d. was calculated per gender group. Where summary statistics have been provided for separate ethnic groups within a study, data have been presented separately.
Results
The search criteria identified 1268 studies. Of these, 392 were excluded as the title indicated that they were non-human, non-cardiac, did not involve echocardiography, or were related to the fetal, pediatric or adolescent heart. Abstracts on the remaining 876 were reviewed with reference to the full text as needed. From these, 821 studies were excluded which: did not screen for CVD or high blood pressure (BP); did not discuss LVM; were not from a general population of adults; had a total study size p20; used a control group (Figure 1 ). After detailed review of the full text of the publication, a further 22 studies were excluded for being from the same cohort, or when summary statistics for each gender could not be obtained from the publication or author.
Cohorts
A total of 33 studies representing 15 500 people (39% women) met the inclusion criteria and formed the basis of this review (Table 1) . Median study size was 141 people (range . Although the range of ages within studies varied, the spectrum of adult ages was represented. Three studies contained at least two ethnically defined cohorts each and results are presented per cohort.
All geographical regions of the world were represented. In all, 11 studies representing 7542 people from North America (49% of available data), nine studies from Europe (31%), four from Asia (8.3%), three from the Middle East (6.3%), three from South America (3.3%), two from Australasia (1.8%) and one from Africa (0.6%).
Studies varied in their criteria for excluding subjects with hypertension; however, all had at least one of a known history, being on medication for high BP or meeting pre-determined hypertensive BP thresholds. In all, 15 studies excluded people with a history of diabetes, and in two studies it was either not clear or not all subjects were excluded on the basis of diabetes. In all, 13 studies excluded subjects on the basis of being overweight or obese, characterised mainly by body mass index (BMI). Figure 2 summarises the range of LVM measured from m-mode and two-dimensional images. The data used to create the recommended reference ranges are unpublished; 4 however, a sample of the data used to create the m-mode ranges are presented at the bottom of the plots. 12 The range of LVMI by m-mode or two dimensional is summarised in Figure 3 .
Left ventricular mass by country
Few of the ranges from normal cohorts fell within the reference ranges recommended by the ASE, and there was heterogeneity in values of LVM both within and between countries.
Men
In men, the upper range of LVM per study exceeded the upper limit of the m-mode ASE reference ranges by 16-58 g (mean 31 g) (Figure 2a) . Therefore of the 13 cohorts (12 studies) of normal healthy men that would be classified as including people with mild LVH, five would also contain men with moderate LVH. [13] [14] [15] [16] [17] The LVM from eight cohorts matched the upper ASE reference limit ( ± 10 g) 12, [18] [19] [20] [21] [22] [23] [24] (two studies included subjects from the cohorts used to create the reference range, 12, 22 and one appears to be the study on which the twodimensional reference ranges were based 23 ), and LVM from seven cohorts was less than the upper ASE reference limit. 12, [25] [26] [27] [28] [29] [30] Of those that were less than the upper ASE reference limit, three studies from Asia 25, 26, 30 had upper values on average 38 g less than the ASE reference limits for m-mode or two-dimensional measurements. A cohort of American Blacks included in the development of the ASE Systematic review of left ventricular mass KK Poppe et al reference ranges were 25 g less, 12 another study from the US was up to 41 g less, 29 and two cohorts from Brazil were 15 g less. 27, 28 These results suggest that LVM well outside the normal range is required in these populations before meeting the threshold for LVH.
Indexation of mass by BSA did not remove the disparity between studies and the reference ranges (Figure 3a) . Of the 24 cohorts that report both indexed and unindexed mass, nine still exceeded the upper ASE reference limit for LVMI ( ± 5 g m À2 ) [13] [14] [15] 17, 21, [30] [31] [32] [33] and five had ranges up to 29 g m À2 below the upper ASE reference limit. 12, 19, 25, 27, 29 Women In women, the range of measured LVM was compatible with the ASE reference range in a greater number of studies than in men; however, LVM from eight cohorts (seven studies) still exceeded the upper ASE reference value by 11-92 g (mean 40 g) (Figure 2b) . [15] [16] [17] 22, 31, 32, 34 A greater proportion of the range of mass exceeded the upper ASE reference limit than it did in men, with the most extreme situation being in Jordanian women, where mean LVM was above the upper ASE reference limit. Of these eight cohorts, six contained women that would be classified as having moderate LVH 16, 17, 31, 32, 34 and one contained women with 12, 20, 25, 29 Of these, Chinese women were at least 20 g less and Belgium women at least 10 g less. The two remaining cohorts were American including that of American Blacks included in a study used to develop the ASE reference ranges, 12 which were 14 g less than the upper ASE reference limit.
As occurred in men, indexation of mass by BSA did not remove the disparity between studies and the reference ranges, and actually seemed to increase the heterogeneity (Figure 3b ). Of the 12 cohorts with an upper value within 10 g of the upper ASE reference limit for LVM, three were reclassified as exceeding the upper ASE reference 26, 28, 30 and one reclassified as falling below the upper ASE reference 24 after indexation by BSA.
Impact of co-morbidities
People that were overweight or had a history of diabetes were excluded from the data used to create the ASE reference ranges. Not all studies in this review excluded subjects on this basis; however, of those that did 17, 18, 20, 21, 25, 26, 35 two studies of American men 17, 35 and one of American women 17 still exceeded the upper ASE reference limit of LVM. Chinese men and women and Indian men were still lower. 
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Systematic review of left ventricular mass KK Poppe et al
The threshold that defined high BP varied across studies. Studies with a threshold for normal BP higher than 140/90 mm Hg 14, 31, 36, 37 were among the studies that exceeded the upper ASE reference limit, suggesting that for at least some of the subjects in these studies, their increased LVM may have been due to mild hypertension. The average BP for these studies ranged from 118/74 (ref. 37 ) to 129/ 82 mm Hg, 14 compared with the range across all studies of 106/68-136/71 mm Hg, suggesting the distributions in this group were not significantly skewed towards higher BP (Table 1) .
Discussion
Classification of LVH by echocardiography (defined as an abnormal increase in LVM) requires an appropriate normal reference range. Ideally, this range would be derived from a representative cohort of healthy volunteers without signs or symptoms of cardiovascular disease. This systematic review collated published normal ranges for echocardiographically derived LVM from 33 studies, involving more than 15 000 people from all the inhabited continents of the world. The results demonstrate wide disparity in normal ranges across the studies and countries, with many falling outside the values recommended by the ASE Guidelines for Chamber Quantification, 4 whether unindexed or indexed to BSA.
The ASE reference limits for LVM are based on an unpublished series of ethnically diverse people without cardiovascular disease from the US. The current review demonstrates that cohorts in many western countries exceed the upper ASE reference Systematic review of left ventricular mass KK Poppe et al limit, and even within countries from which the reference limits have been derived, they do not appear consistent. The upper limits of current ASE reference ranges far exceed the values in a normal population from Asia or the Indian subcontinent, underdiagnosing LVH in these groups. People from this region constitute a large proportion of the world's population, and thus there are potentially a large number of people who will not be recognised to have LVH when compared with the current guidelines. In contrast, the upper limit of the ASE reference range is less than the upper value in normal cohorts from Europe, the Middle East and North America, and as a result may overdiagnose LVH in these groups. Many regions of the world have populations with a mixture of ethnicities and a reference range (or ranges) derived from predominantly Caucasian individuals is thus inappropriate. Ideally, reference ranges need to be established for all ethnic groups, incorporating a large sample size and a wide range of individuals free of risk factors for increased LVM such as increased BP.
LVM is affected by many factors including age, gender, body size and composition, 6, 7 athletic training, 38 blood pressure 39, 40 and systemic disease processes such as diabetes. 41 To account for the influence of body composition on LVM, various estimates of body size have been used to normalise LVM, including dividing mass by BSA 42 or by height 2.7 (ref. 22) . BSA has been widely used and remains a recommendation in the ASE guidelines, and was therefore the focus of this review. It has shown that indexation by BSA does not improve the relevance of the recommended reference ranges in either gender, and does not appear to account for differences between populations.
Allometric indexation, such as dividing by height 2.7 , may be a more suitable approach to scaling LVM for body size. 43 Indexing to a power of height is the most widely accepted method of indexation in older children, but it is less consistently applied in adults. Of people with hypertension, LVH may be underdiagnosed in those that are obese, where measured mass may be elevated; however, it is incorrectly compensated for by adjusting for BSA. In contrast, if an obese person with hypertension loses weight, their decrease in BSA would increase the calculated LVMI, even though BP remains the same or decreases with weight loss. Indexation to height alleviates this problem; however, it does not take in to account differences in body composition that may occur between individuals of similar height, especially across ethnic groups.
It is difficult, if not impossible, to differentiate early pathophysiological adaptations to CV risk factors from the effects of the 'normal' aging process on the heart. The relationship between risk factors and increasing LVM is continuous, with increasing levels of a risk factor associated with increasing LVM across the range of values. For example, BP has a continuous positive relationship with LVM. 1 To categorise this relationship, pre-hypertension has been defined as persistent systolic values of 120-139 mm Hg or diastolic values of 80-89 mm Hg, 44 which has been shown to be associated with LVH and deleterious changes in cardiac function. 45 The studies in this review excluded subjects that were defined as hypertensive, however by this definition, will contain people currently defined as pre-hypertensive.
The current review suggests that ethnicity may be a significant contributor to the between-country differences that are seen. In health, LVM is largely determined by the metabolic requirements of LBM, 5, 6 which differs between ethnic groups. Compared with Caucasians, LBM is higher in American Blacks 46 and lower in Asian Indians. 8 Therefore in disease, LVH may be underdiagnosed in Asian Indians, where measured LVM may appear normal; however, their small build and low LBM is compatible with a lower LVM and as such will remain undetected. Indexation by BSA in this group with proportionally greater abdominal fat 'forgives' the effects of central fat or obesity on LVM, whereas indexing by a measure of LBM may avoid underestimating LVH. Thus, an alternative approach to indexation may be to use a method such as LBM that more accurately accounts for the differences in body composition across ethnic groups than BSA or height. Possible limitations with this approach are that LBM can be difficult to measure, and the relationship between outcome and LVM indexed to LBM remains uncertain, as does the relationship between LVM and prognosis within ethnicities. 47 
Limitations
The potential for publication bias and duplication of published data inherent to many literature reviews was minimised in this study. Values for LVM in normal healthy cohorts were not derived from interventional studies that expect a positive or negative result, so are less prone to publication bias. Other than one study that included subjects derived from a cohort used to develop the ASE reference ranges, only one study per cohort was retained in this review. However, inappropriate exclusion of studies from the review may have occurred if the abstract did not state or strongly suggest that LVM had been measured.
Studies varied in the measurement convention (ASE or Penn), mass equation and screening criteria (definition of hypertension, diabetes and overweight) that were used. The ASE recommends measuring images using the leading edge to leading edge convention and calculating LVM with the cubed formula. 10 To clarify any effect that a different approach may have had, studies that used the Penn convention have been highlighted, and mass from leading edge measurements recalculated where possible. The recommended reference ranges were developed in people without diabetes and with a BMI o26 kg m À2 , 12 as did three other studies in this review. This is the universal definition of being overweight and at increased risk of disease; however, the World Health Organisation suggests that a lower threshold of BMI is associated with similar health risks in Asians.
Some of the variability in these cohorts may have been reduced if more accurate assessment of LVM were undertaken, such as with three-dimensional echo or magnetic resonance imaging. However, these data represent the real world where assessment of LVH, especially in hypertensive patients, is typically obtained from transthoracic echocardiography.
Discussion of ethnicity was limited to countrylevel definitions as details of the ethnic mix, and data on LVM per ethnic group, depended on the focus of the individual study. Therefore analysis of LVM in individual ethnic groups could not be performed.
Conclusion
These data suggest that current reference ranges of LVM may not be easily applied to the diverse multiracial world population with CV disease. Ethnicspecific reference ranges may need to be developed, or alternatively, a method of indexation that more accurately reflects LBM and thus incorporates an important factor influencing LVM. LVH has emerged as an important prognostic marker and is a target for pharmacological intervention, with a decrease in mass associated with a lower probability of experiencing an event. Therefore it is paramount that we determine accurate thresholds of 'normal' LVM in all people.
Clinical implications
Echocardiography is a widely used tool in the hypertensive population and is the optimal method for detecting LVH, but detection needs to be appropriate. The dispersion of echocardiographically derived ranges for LVM shown in this review suggests that if current ASE guidelines are used to define LVM as 'normal' than a number of patients may be misclassified. This misclassification may lead to underdiagnosis of LVH and ultimately undertreatment and underestimation of the prognostic importance of LVH in subgroups of patients.
